PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-10-03

Date Title Company
03-Oct-2023 Global Multi-Therapy Infusion Pumps Market is expected to reach US$ 699.4 Million by 2033, growing at a CAGR of 6.6% MARKITWIRED
03-Oct-2023 For the First Time, Researchers Successfully Demonstrate Over euNetworks’ Fibre Infrastructure That Quantum Communication Is Possible Between the United Kingdom and Ireland Businesswire
03-Oct-2023 Infusion Pumps Market: Leading the Way in Patient Care with a Projected Value of US$ 6.6 Billion by 2030 MARKITWIRED
03-Oct-2023 Cervical Cancer Screening Market to Reach US$ 5.7 Billion by 2033, Driven by Rising Prevalence and Technological Advancements | FMI MARKITWIRED
03-Oct-2023 Wound Debridement Products Market: Charting a Course to a US$ 7.52 Billion Future by 2033 MARKITWIRED
03-Oct-2023 Gamma Knife Market: Spearheading Neurosurgery Advancements with a Projected 2033 Value of US$ 600 Million MARKITWIRED
03-Oct-2023 Renal Biomarkers Market Poised for Remarkable Growth, Anticipated to Surpass US$ 2.6 Billion by 2032 MARKITWIRED
03-Oct-2023 Ganymed Robotics Announces Appointment of Seasoned Leadership Team to Bring to Market Its Next Generation Surgical Technology Businesswire
03-Oct-2023 Takeda Fornece Atualização sobre EXKIVITY® (mobocertinib) Businesswire
03-Oct-2023 Portable Oxygen Concentrators Market Breathing Easy Towards a US$ 5.0 Billion Milestone by 2032, Set to Surpass Expectations MARKITWIRED
03-Oct-2023 Roche to present new key clinical and real-world data at ECTRIMS-ACTRIMS 2023 showcasing strength of long-term outcomes in MS and NMOSD Roche
03-Oct-2023 Sanofi announces agreement for potential first-in-class vaccine against extraintestinal pathogenic E. coli Sanofi
03-Oct-2023 Takeda Provides Update on EXKIVITY® (mobocertinib) Takeda
03-Oct-2023 R21/Matrix-M™ Malaria Vaccine with Novavax’s Adjuvant Technology Receives WHO Recommendation Novavax
03-Oct-2023 Oxford BioTherapeutics Announces Partner Boehringer Ingelheim Received U.S. FDA Fast Track Designation for BI 764532 for the Treatment of Extensive Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancers Oxford BioTherapeutics
03-Oct-2023 Biohaven Announces Pricing of $225 Million Public Offering of Common Shares Biohaven
03-Oct-2023 Immix Biopharma Announces 72-Patient NXC-201 Clinical Data at the IMS 20th Annual Meeting, 95% Overall Response Rate in Multiple Myeloma Immix Biopharma
03-Oct-2023 Cassava Sciences Completes Patient Enrollment for Pivotal Phase 3 Clinical Trial of Oral Simufilam in Alzheimer’s Disease Cassava Sciences
03-Oct-2023 King Faisal Specialist Hospital & Research Centre Achieves Medical Milestone with World's First Fully Robotic Liver Transplant King Faisal Specialist Hospital & Research Centre
03-Oct-2023 The Oxford-Harrington Rare Disease Centre Launches Pioneering Therapeutics Accelerator to Advance Innovative Treatments for Rare Diseases The Oxford-Harrington Rare Disease Centre